Latest Deep vein thrombosis Stories
The Firm is actively investigating potential claims on behalf of patients who allegedly suffered Xarelto internal bleeding, strokes, pulmonary embolism and/or deep vein thrombosis following use
CHICAGO, July 15, 2014 /PRNewswire/ -- At the encouragement of the patient safety community, the Physician-Patient Alliance for Health & Safety (PPAHS) has introduced the PPAHS Patient
The Firm is investigating testosterone treatment lawsuits on behalf of men who suffered serious cardiovascular events, including heart attacks, strokes, deep vein thrombosis, and pulmonary embolism,
Zoll, Kranz & Borgess, LLC currently represents clients with injuries allegedly caused by testosterone therapy. Toledo, OH (PRWEB) July 03, 2014
At the California Institute for Deep Venous Thrombosis, Dr.
The DrugNews Center is the web’s largest source for prescription drug warnings, research and legal news.
FDA now requires general product label warnings about increased risk ALTON, Ill., June 24, 2014 /PRNewswire/ -- The U.S.
The Firm is evaluating testosterone treatment lawsuits on behalf of men who may have suffered life-threatening cardiovascular injuries, including heart attacks, strokes and blood clots, due to
The US Food and Drug Administration (FDA) is now requiring manufacturers of testosterone supplements to include a general warning label about the risk of blood clots in the veins.
In an analysis that included data from 16 trials performed over the last 45 years, among patients with pulmonary embolism, receipt of therapy to dissolve the blood clot (thrombolysis) was associated with lower rates of death, but increased risks of major bleeding and intracranial hemorrhage.
- The abrogation of a law by a higher authority; annulment.